Literature DB >> 33778862

Invited Commentary: Dealing With the Inevitable Deficiencies of Bias Analysis-and All Analyses.

Sander Greenland.   

Abstract

Lash et al. (Am J Epidemiol. 2021;190(8):1604-1612) have presented detailed critiques of 3 bias analyses that they identify as "suboptimal." This identification raises the question of what "optimal" means for bias analysis, because it is practically impossible to do statistically optimal analyses of typical population studies-with or without bias analysis. At best the analysis can only attempt to satisfy practice guidelines and account for available information both within and outside the study. One should not expect a full accounting for all sources of uncertainty; hence, interval estimates and distributions for causal effects should never be treated as valid uncertainty assessments-they are instead only example analyses that follow from collections of often questionable assumptions. These observations reinforce those of Lash et al. and point to the need for more development of methods for judging bias-parameter distributions and utilization of available information.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords:  Bayesian methods; bias; epidemiologic methods; observational studies; uncertainty analysis

Year:  2021        PMID: 33778862     DOI: 10.1093/aje/kwab069

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  3 in total

1.  RE: "TRENDS IN 'DEATHS OF DESPAIR' AMONG WORKING-AGED WHITE AND BLACK AMERICANS, 1990-2017".

Authors:  Samantha Eiffert; Catherine X Li; Kurtis Anthony; Charles Poole
Journal:  Am J Epidemiol       Date:  2022-01-24       Impact factor: 5.363

2.  Are Greenland, Ioannidis and Poole opposed to the Cornfield conditions? A defence of the E-value.

Authors:  Tyler J VanderWeele
Journal:  Int J Epidemiol       Date:  2022-05-09       Impact factor: 9.685

3.  Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.

Authors:  Joseph Fraiman; Juan Erviti; Mark Jones; Sander Greenland; Patrick Whelan; Robert M Kaplan; Peter Doshi
Journal:  Vaccine       Date:  2022-08-31       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.